Literature DB >> 16136458

Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics.

Samreen Ijaz1, Eve Arnold, Malcolm Banks, Richard P Bendall, Matthew E Cramp, Richard Cunningham, Harry R Dalton, Tim J Harrison, Simon F Hill, Lorna Macfarlane, Rolf E Meigh, Shuja Shafi, Martin J Sheppard, Jacquie Smithson, Melanie P Wilson, Chong-Gee Teo.   

Abstract

Between 1996 and 2003, 186 cases of hepatitis E were serologically diagnosed. Of these, 17 (9%) were not associated with recent travel abroad. Patients were >55 years old (range, 56-82 years old) and tended to be male (76%). Two patients presented with fulminant hepatitis. A total of 129 (69%) cases were associated with recent travel to countries where hepatitis E virus (HEV) is hyperendemic. Compared with patients with travel-associated disease, patients with non-travel-associated disease were more likely to be older, living in coastal or estuarine areas, not of South Asian ethnicity, and infected by genotype 3 strains of HEV. The genotype 3 subgenomic nucleotide sequences were unique and closely related to those from British pigs. Patients infected by HEV indigenous to England and Wales tended to belong to a distinct demographic group, there were multiple sources of infection, and pigs might have been a viral reservoir.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16136458     DOI: 10.1086/444396

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  60 in total

1.  Serological and molecular study of hepatitis E virus among illegal blood donors.

Authors:  Xian-Feng Cheng; Yu-Feng Wen; Ming Zhu; Sheng-Wei Zhan; Jin-Xiu Zheng; Chen Dong; Ke-Xia Xiang; Xiao-Bing Xia; Gang Wang; Ling-Fei Han
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Early qualitative risk assessment of the emerging zoonotic potential of animal diseases.

Authors:  Stephen Palmer; David Brown; Dilys Morgan
Journal:  BMJ       Date:  2005-11-26

3.  Indigenous hepatitis E virus infection in England and Wales.

Authors:  Hannah Lewis; Dilys Morgan; Samreen Ijaz; Elizabeth Boxall
Journal:  BMJ       Date:  2006-06-24

4.  Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.

Authors:  Michael J Ankcorn; Samreen Ijaz; John Poh; Ahmed M Elsharkawy; Erasmus Smit; Robert Cramb; Swathi Ravi; Kate Martin; Richard Tedder; James Neuberger
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

5.  Neuralgic amyotrophy and hepatitis E virus infection.

Authors:  Jeroen J J van Eijk; Richie G Madden; Annemiek A van der Eijk; Jeremy G Hunter; Johan H J Reimerink; Richard P Bendall; Suzan D Pas; Vic Ellis; Nens van Alfen; Laura Beynon; Lucy Southwell; Brendan McLean; Bart C Jacobs; Baziel G M van Engelen; Harry R Dalton
Journal:  Neurology       Date:  2014-01-08       Impact factor: 9.910

6.  Guess who's coming to dinner? Emerging foodborne zoonoses.

Authors:  David N Fisman; Kevin Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

7.  Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Authors:  H E Ambrose; J Granerod; J P Clewley; N W S Davies; G Keir; R Cunningham; M Zuckerman; K J Mutton; K N Ward; S Ijaz; N S Crowcroft; D W G Brown
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

8.  Hepatobiliary quiz-8 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-12

9.  Transfusion-associated hepatitis E, France.

Authors:  Philippe Colson; Carole Coze; Pierre Gallian; Mireille Henry; Philippe De Micco; Catherine Tamalet
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

10.  Hepatitis E outbreak on cruise ship.

Authors:  Bengü Said; Samreen Ijaz; George Kafatos; Linda Booth; H Lucy Thomas; Amanda Walsh; Mary Ramsay; Dilys Morgan
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.